General Information of Drug Transporter (DT)
DT ID DTD0300 Transporter Info
Gene Name SLC35D3
Transporter Name Fringe connection-like protein 1
Gene ID
340146
UniProt ID
Q5M8T2
Post-Translational Modification of This DT
Overview of SLC35D3 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Phosphorylation X: Amino Acid

Phosphorylation

  Serine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC35D3 [1]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

77

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35D3 Serine 77 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC35D3 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

95

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35D3 Serine 95 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC35D3 [3] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

415

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35D3 Serine 415 has the potential to affect its expression or activity.

  Threonine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC35D3 [1]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

92

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35D3 Threonine 92 has the potential to affect its expression or activity.

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC35D3 [5]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

311

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC35D3 Tyrosine 311 has the potential to affect its expression or activity.
References
1 Quantitative phosphoproteomics of Alzheimer's disease reveals cross-talk between kinases and small heat shock proteins. Proteomics. 2015 Jan;15(2-3):508-519.
2 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
3 Phosphoproteins in extracellular vesicles as candidate markers for breast cancer. Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):3175-3180.
4 Global phosphoproteomics of CCR5-tropic HIV-1 signaling reveals reprogramming of cellular protein production pathways and identifies p70-S6K1 and MK2 as HIV-responsive kinases required for optimal infection of CD4+ T cells. Retrovirology. 2018 Jul 3;15(1):44.
5 Neuroblastoma tyrosine kinase signaling networks involve FYN and LYN in endosomes and lipid rafts. PLoS Comput Biol. 2015 Apr 17;11(4):e1004130.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.